[1]简军 殷跃辉.APPLE评分与心房颤动[J].心血管病学进展,2020,(6):616.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.014]
 JIAN Jun,YIN Yuehui.The APPLE Score and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(6):616.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.014]
点击复制

APPLE评分与心房颤动()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年6期
页码:
616
栏目:
综述
出版日期:
2020-06-25

文章信息/Info

Title:
The APPLE Score and Atrial Fibrillation
作者:
简军 殷跃辉
(1.重庆医科大学研究生院,重庆400010;2.重庆医科大学附属第二医院心血管内科,重庆400010)
Author(s):
JIAN Jun1 YIN Yuehui2
Chongqing Medical University Graduate School,Chongqing 400010,China; 2. Department of Cardiology,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
关键词:
心房颤动APPLE评分射频消融
Keywords:
Atrial fibrillation APPLE score Radiofrequency ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2020.06.014
摘要:
APPLE评分是预测心房颤动(房颤)射频消融术后复发的风险预测评分,其包括年龄>65岁、持续性心房颤动、慢性肾功能不全[eGFR≤60 mL/(min·1.73 m2)]、左心房直径≥43 mm和左心室射血分数<50%,每项危险因素各赋值1分,范围从0~5分。近年来关于APPLE评分在预测房颤消融术后复发的研究已成为临床热点话题之一,提示APPLE评分对房颤射频消融术后复发患者的危险分层具有较好的预测价值。现对国内外关于APPLE评分的临床应用及最新进展进行简要综述,以了解APPLE评分的研究现状及相关研究带来的启示。
Abstract:
The APPLE score is a scoring system to predict the recurrence of atrial fibrillation after radiofrequency ablation of atrial fibrillation. It includes age >65 years old,persistent atrial fibrillation,impaired eGFR[eGFR≤60mL/(min·1.73 m2],left atrial diameter≥43 mm and left ventricular ejection fraction<50%,each risk factor is assigned 1 point,with a score from 0 to 5 points. In recent years,the study of APPLE score in predicting the recurrence of atrial fibrillation after ablation has become one of the hot topics in clinical practice,suggesting that the APPLE score has a good predictive value for the risk stratification of patients with atrial fibrillation recurrence after ablation. In this paper,the clinical application and the latest development of APPLE score at home and abroad are briefly reviewed,in order to understand the research status of APPLE score and the enlightenment of related research.

参考文献/References:


[1] Kornej J,Hindricks G,Kosiuk J,et al. Comparison of CHADS2,R2CHADS2,and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation:the Leipzig Heart Center AF Ablation Registry[J]. Circ Arrhythm Electrophysiol ,2014,7(2):281-287.

[2] Kornej J,Hindricks G,Shoemaker MB,et al. The APPLE score:a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation[J]. Clin Res Cardiol ,2015,104(10):871-876.

[3] Dagres N,Clague JR,Lottkamp H,et al. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age[J]. Eur Heart J ,2001,22(5):423-427.

[4] Zhang XD,Gu J,Jiang WF,et al. The impact of age on the efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation[J]. Int J Cardiol ,2013,168(3):2693-2698.

[5] 陈英伟. 年龄对心房颤动患者导管消融术长期预后的影响[J]. 中华老年医学杂志 ,2016,12(35):1283-1287.

[6] Yanagisawa S,Inden Y,Kato H,et al.Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation:a potential effect of non-pulmonary vein foci[J]. J Cardiol ,2017,69(1):3-10.

[7] Deng H,Shantsila A,Xue Y,et al. Renal function and outcomes after catheter ablation of patients with atrial fibrillation:The Guangzhou atrial fibrillation ablation registry[J]. Arch Cardiovasc Dis,2019,112(6-7):420-429.

[8] McCready JW,Smedley T,Lambiase PD,et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation[J]. Europace ,2011,13(3):355-361.

[9] Kalil C,Bartholomay E,Borges A,et al. Atrial fibrillation ablation by use of electroanatomical mapping:efficacy and recurrence factors[J]. Arq Bras Cardiol ,2014,102(1):30-38.

[10] 陈佳磊. 心房颤动射频导管消融现状[J]. 心血管病学进展 ,2018,39(6):893-896.

[11] Chang HY,Lo LW,Lin YJ,et al. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy[J]. J Cardiovasc Electrophysiol ,2013,24(3):250-258.

[12] Sultan A,Luker J,Andresen D,et al. Predictors of atrial fibrillation recurrence after catheter ablation:data from the German Ablation Registry[J]. Sci Rep ,2017,7(1):16678.

[13] Ullah W,Ling LH,Prabhu S,et al. Catheter ablation of atrial fibrillation in patients with heart failure:impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death[J]. Europace ,2016,18(5):679-686.

[14] Zhao Y,Di Biase L,Trivedi C,et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction[J]. Heart Rhythm ,2016,13(1):141-149.

[15] Furukawa Y,Yamada T,Morita T,et al. A novel and simple risk score for the prediction of recurrence of atrial fibrillation after radio frequency catheter ablation[J]. Eur Heart J,2016,37:1086.

[16] Kornej J,Hindricks G,Arya A,et al. The APPLE Score—A novel score for the prediction of rhythm outcomes after repeat catheter ablation of atrial fibrillation[J]. PLoS One ,2017,12(1):e0169933.

[17] Mujovi? N, Marinkovi? M, Markovi? N,et al. Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation:the MB-LATER clinical score[J]. Sci Rep ,2017,7:40828.

[18] Schumacher K,Kornej J,Bollmann A,et al. Prediction of very late arrhythmia recurrence after catheter ablation in patients with atrial fibrillation using APPLE and MB-LATER scores:the Leipzig AF ablation registry[J]. Eur Heart J ,2018,39(suppl 1):ehy564.367.

[19] Kornej J,Schumacher K,Zeynalova S,et al. Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation:the Leipzig Heart Center AF Ablation Registry[J]. Sci Rep ,2019,9(1):7112.

[20] Kornej J,Schumacher K,Sommer P,et al. Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation:the Leipzig Heart Center AF Ablation Registry[J]. Europace ,2019,21(11):1646-1652.

[21] Deng H,Shantsila A,Xue Y, et al. Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation:the Guangzhou atrial fibrillation project[J]. Int J Clin Pract ,2018,72(11):e13247.

[22] Deng H,Shantsila A,Guo P,et al. Sex-related risks of recurrence of atrial fibrillation after ablation:Insights from the Guangzhou Atrial Fibrillation Ablation Registry[J]. Arch Cardiovasc Dis ,2019,112(3):171-179.

[23] Rolf S,Kircher S,Arya A,et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation[J]. Circ Arrhythm Electrophysiol ,2014,7(5):825-833.

[24] Kornej J,Schumacher K,Dinov B,et al. Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE,DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation[J]. Sci Rep ,2018,8(1):12686.

[25] Kosiuk J,Dinov B,Kornej J,et al. Prospective,multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis:DR-FLASH score[J]. Heart Rhythm ,2015,12(11):2207-2212.

[26] Kornej J,Buttner P,Sommer P,et al. Prediction of electro-anatomical substrate using APPLE score and biomarkers[J]. Europace ,2019,21(1):54-59.

[27] Blandino A,Bianchi F,Grossi S,et al. Left Atrial substrate modification targeting low-voltage areas for catheter ablation of atrial fibrillation:a systematic review and meta-analysis[J]. Pacing Clin Electrophysiol ,2017,40(2):199-212.

[28] Mujovi? N,Marinkovi? M,Vucicevi? V ,et al. Comparison of different clinical scoring systems for predicting atrial arrhythmia recurrence following catheter ablation of atrial fibrillation [J]. Europace ,2019,21:ii610-ii611.

[29] Bavishi AA,Kaplan RM,Peigh G,et al. Patient characteristics as predictors of recurrence of atrial fibrillation following cryoballoon ablation[J]. Pacing Clin Electrophysiol,2019,42(6):694-704.

[30] Canpolat U,Aytemir K,Yorgun H,et al. A proposal for a new scoring system in the prediction of catheter ablation outcomes:promising results from the Turkish Cryoablation Registry[J]. Int J Cardiol ,2013,169(3):201-206.

[31] Glowniak A,Tarkowski A,Wojewoda K,et al. Atrial Fibrillation ablation with multipolar phased-radiofrequency catheter:the learning curve effect for procedural parameters,but not for the long-term outcome[J]. J Clin Med ,2019,8(10):1589.

[32] Jud FN,Obeid S,Duru F,et al. A novel score in the prediction of rhythm outcome after ablation of atrial fibrillation:the SUCCESS score[J]. Anatol J Cardiol,2019,21(3):142-149.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
 HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(6):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
 DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(6):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
 ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
 ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
 HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
 WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
 XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(6):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
 ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(6):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
 WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(6):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
 ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(6):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]

更新日期/Last Update: 2020-09-22